Prokarium is a biotechnology company with a vision to create the best platform for oral delivery of protein vaccines. Our synthetic biology platform Vaxonella makes vaccines more accessible to travellers and people living in rural and resource-poor areas
Prokarium to present at the World Vaccine Congress
Prokarium’s team is attending the World Vaccine Congress in Brussels 13-15 October 2014. Rocky Cranenburgh will present on bringing Prokarium’s lead vaccine Typhetec from preclinical research to clinical development.